Last Updated:
Searching
Create account to add to watchlist!
Create account to add to watchlist!

Crypto 1 Acquisition Corp - DAOO

  • Commons

    $9.91

    +0.00%

    DAOO Vol: 0.0

  • Warrants

    $0.14

    +0.00%

    DAOOW Vol: 0.0

  • Units

    $9.97

    +0.00%

    DAOOU Vol: 0.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 227.9M
Average Volume: 34.3K
52W Range: $9.75 - $9.99
Weekly %: +0.20%
Monthly %: +0.10%
Inst Owners: 0

Info

Target: Searching
Days Since IPO: 210
Unit composition:
Each unit has an offering price of $10.00 and consists of one Class A ordinary share and three-quarters of one warrant
Trust Size: 20000000.0M

Management

Officers and Directors Cayman Islands law does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against willful default, willful neglect, civil fraud or the consequences of committing a crime. Our amended and restated memorandum and articles of association will provide for indemnification of our officers and directors to the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through their own actual fraud, willful default or willful neglect. 114 We will enter into agreements with our officers and directors to provide contractual indemnification in addition to the indemnification provided for in our amended and restated memorandum and articles of association. Our amended and restated memorandum and articles of association also will permit us to purchase and maintain insurance on behalf of any officer or director who at the request of the company is or was serving as a director or officer of, or in any other capacity is or was acting for, another company or a partnership, joint venture, trust or other enterprise, against any liability asserted against the person and incurred by the person in that capacity, whether or not the company has or would have had the power to indemnify the person against the liability as provided in the amended and restated memorandum and articles of association. We will seek to purchase a policy of directors’ and officers’ liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors. These provisions may discourage shareholders from bringing a lawsuit against our directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against officers and directors, even though such an action, if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder’s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these indemnification provisions. We believe that these provisions, the insurance and the indemnity agreements are necessary to attract and retain talented and experienced officers and directors. 115 PRINCIPAL SHAREHOLDERS The following table sets forth information regarding the beneficial ownership of our ordinary shares as of the date of this prospectus and as adjusted to reflect the sale of our ordinary shares included in the units offered by this prospectus (assuming none of the individuals listed purchase units in this offering), by: · each person known by us to be the beneficial owner of more than 5% of our outstanding ordinary shares; · each of our executive officers, directors and director nominees that beneficially owns ordinary shares; and · all our executive officers and directors as a group. Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary shares beneficially owned by them. The following table does not reflect record of beneficial ownership of any Class A ordinary shares issuable upon exercise of outstanding warrants as such warrants are not exercisable within 60 days of the date of this prospectus. On June 16, 2021, we issued an aggregate of 5,750,000 founder shares to our sponsor for a total subscription price of $25,000, or approximately $0.004 per share. Such shares are fully paid. The following table presents the number of shares and percentage of our ordinary shares owned by our sponsor before and after this offering. The post-offering numbers and percentages presented assume that the underwriters do not exercise their option to purchase additional units, that the sponsor forfeits an aggregate of 750,000 founder shares and that there are 25,000,000 ordinary shares issued and outstanding after this offering. Before Offering After Offering Name and Address of Beneficial Owner(1) Number of Ordinary Shares Beneficially Owned(2) Approximate Percentage of Outstanding Ordinary Shares Number of Ordinary Shares Beneficially Owned Approximate Percentage of Outstanding Ordinary Shares Crypto 1 Sponsor LLC(3) 5,750,000 100% 5,000,000 20% David Hytha(3) 5,750,000 100% 5,000,000 20% Dr. Najamul Kidwai - - - - Michael (Xu) Zhao - - - - David Maloy - - - - Jeffrey Singer - - - - Alvin Eng - - - - Matthew Krna - - - - Faisal Galaria - - - - All directors, director nominees and executive officers as a group (eight individuals) 5,750,000 100% 5,000,000 20% * Less than one percent. (1) Unless otherwise noted, the business address of each of the entities or individuals is c/o Crypto 1 Acquisition Corp, 1221 Brickell Avenue Suite 900, Miami, Florida 33131. (2) Interests shown consist solely of founder shares, classified as Class B ordinary shares. Such shares will automatically convert into Class A ordinary shares at the time of our initial business combination or earlier at the option of the holders thereof as described in the section entitled “Description of Securities.” (3) These securities are held directly by Crypto 1 Sponsor LLC, our sponsor. David Hytha is the Managing Member and controls our sponsor, and may be deemed to beneficially own the securities held by our sponsor. Mr. Hytha disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. 116 Immediately after this offering, our initial shareholders will beneficially own founder shares equal to 20% of the then-issued and outstanding public shares and founder shares. If we increase or decrease the size of the offering, we will effect a share dividend or share surrender or redemption or other appropriate mechanism, as applicable, immediately prior to the consummation of the offering in such amount as to maintain the ownership of founder shares by our initial shareholders at 20% of our issued and outstanding public shares and founder shares upon the consummation of this offering. Because of this ownership block, our sponsor may be able to effectively influence the outcome of all matters requiring approval by our shareholders, including the appointment of directors, amendments to our amended and restated memorandum and articles of association and approval of significant corporate transactions other than approval of our initial business combination. The founder shares are identical to the Class A ordinary shares included in the units being sold in this offering except as described herein. However, the holders have agreed (i) to vote any shares owned by them in favor of any proposed business combination and (ii) not to redeem any shares in connection with a shareholder vote or tender offer to approve or in connection with a proposed initial business combination. Our sponsor and our executive officers and directors are deemed to be our “promoters” as such term is defined under the federal securities laws. Transfer Restrictions on Founder Shares and Private Placement Warrants The founder shares, private placement warrants and any Class A ordinary shares issued upon exercise thereof are subject to transfer restrictions pursuant to lock-up provisions in a letter agreement with us to be entered into by our sponsor. Those lock-up provisions provide that such securities are not transferable, assignable or salable (i) in the case of the founder shares, until one year after the date of the consummation of our initial business combination, or earlier if, subsequent to our initial business combination, (a) the last reported sale price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination or (b) we consummate a subsequent liquidation, merger, share exchange or other similar transaction which results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property; and (ii) in the case of the private placement warrants and the Class A ordinary shares underlying such warrants, until 30 days after the date of the consummation of our initial business combination, except in each case (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members of our sponsor, or any affiliates of our sponsor, (b) in the case of an individual, by gift to a member of one of the members of the individual’s immediate family or to a trust, the beneficiary of which is a member of one of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the shares were originally purchased; (f) in the event of our liquidation prior to the completion of our initial business combination; (g) by virtue of the laws of the Cayman Islands or the sponsor’s constitutional documents or the rights attaching to the equity interests in the sponsor upon dissolution of the sponsor; or (h) in the event of our liquidation, merger, share exchange, reorganization or other similar transaction which results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property subsequent to the completion of our initial business combination; provided, however, that in the case of clauses (a) through (e) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions. 117 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS On June 16, 2021, we issued an aggregate of 5,750,000 founder shares to our sponsor for a total subscription price of $25,000, or approximately $0.004 per share. Such shares are fully paid. The number of founder shares issued was determined based on the expectation that such founder shares would represent 20% of the outstanding public shares and founder shares after this offering. Our sponsor has committed to purchase an aggregate of 7,400,000 (or 8,150,000 if the underwriters’ option to purchase additional units is exercised in full) private placement warrants at a price of $1.00 per warrant (approximately $7,400,000 in the aggregate or $8,150,000 if the underwriters’ option to purchase additional units is exercised in full) in a private placement that will occur simultaneously with the closing of this offering. Each private placement warrant is exercisable for one Class A ordinary share at $11.50 per share. Our sponsor will be permitted to transfer the private placement warrants held by it to certain permitted transferees, including our officers and directors and other persons or entities affiliated with or related to it, but the transferees receiving such securities will be subject to the same agreements with respect to such securities as the sponsor. Otherwise, these private placement warrants will not, subject to certain limited exceptions, be transferable or saleable until 30 days after the completion of our initial business combination. As more fully discussed in “Management — Conflicts of Interest,” if any of our officers or directors (other than our independent directors) becomes aware of an initial business combination opportunity that falls within the line of business of any entity to which he has then current fiduciary or contractual obligations, he may, subject to his fiduciary duties under Cayman Islands law, be required to present such business combination opportunity to such entity prior to presenting such business combination opportunity to us. Our executive officers, directors and director nominees currently have certain relevant fiduciary duties or contractual obligations that may take priority over their duties to us. Commencing on the date of this prospectus, we have agreed to pay our sponsor a total of $10,000 per month, for up to 12 months, which is extendable at our sponsor’s option to up to 18 months, as described herein, for office space, utilities, secretarial and administrative support. Upon completion of our initial business combination or our liquidation, we will cease paying these monthly fees. Other than as described above, no compensation of any kind, including finder’s and consulting fees, will be paid to our sponsor, executive officers and directors, or any of their respective affiliates, for services rendered prior to or in connection with the completion of an initial business combination. However, these individuals will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or their affiliates. Our sponsor has agreed to loan us up to $300,000 to be used for a portion of the expenses of this offering. These loans are non-interest bearing, unsecured and are due at the earlier of December 31, 2021 or the closing of this offering. The loan will be repaid upon the closing of this offering out of the $750,000 of offering proceeds that has been allocated to the payment of offering expenses. In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the private placement warrants, including, as to exercise price, exercisability and exercise period. The terms of such loans have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. 118 After our initial business combination, members of our management team who remain with us may be paid consulting, management or other fees from the combined company with any and all amounts being fully disclosed to our shareholders, to the extent then known, in the tender offer or proxy solicitation materials, as applicable, furnished to our shareholders. It is unlikely the amount of such compensation will be known at the time of distribution of such tender offer materials or at the time of a general meeting held to consider our initial business combination, as applicable, as it will be up to the directors of the post-combination business to determine executive and director compensation. We will enter into a registration rights agreement with respect to the private placement warrants, warrants issuable upon conversion of working capital loans (if any) and the Class A ordinary shares issuable upon exercise of the foregoing, which is described under the section of this prospectus entitled “Description of Securities — Registration Rights.” Related Party Policy We have not yet adopted a formal policy for the review, approval or ratification of related party transactions. Accordingly, the transactions discussed above were not reviewed, approved or ratified in accordance with any such policy. Prior to the consummation of our initial public offering, we will adopt a code of ethics requiring us to avoid, wherever possible, all conflicts of interests, except under guidelines or resolutions approved by our board of directors (or the appropriate committee of our board) or as disclosed in our public filings with the SEC. Under our code of ethics, conflict of interest situations will include any financial transaction, arrangement or relationship (including any indebtedness or guarantee of indebtedness) involving the Company. A form of the code of ethics that we plan to adopt prior to the consummation of our initial public offering is filed as an exhibit to the registration statement of which this prospectus is a part. In addition, our audit committee, pursuant to a written charter that we will adopt prior to the consummation of our initial public offering, will be responsible for reviewing and approving related party transactions to the extent that we enter into such transactions. An affirmative vote of a majority of the members of the audit committee present at a meeting at which a quorum is present will be required in order to approve a related party transaction. A majority of the members of the entire audit committee will constitute a quorum. Without a meeting, the unanimous written consent of all of the members of the audit committee will be required to approve a related party transaction. A form of the audit committee charter that we plan to adopt prior to the consummation of our initial public offering is filed as an exhibit to the registration statement of which this prospectus is a part. We also require each of our directors and executive officers to complete a directors’ and officers’ questionnaire that elicits information about related party transactions. These procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a conflict of interest on the part of a director, employee or officer. To further minimize conflicts of interest, we have agreed not to consummate an initial business combination with an entity that is affiliated with any of our sponsor, officers or directors unless we, or a committee of independent directors, have obtained an opinion from an independent investment banking firm that is a member of FINRA or from an independent accounting firm that our initial business combination is fair to our company from a financial point of view. Furthermore, no finder’s fees, reimbursements or cash payments will be made to our sponsor, officers or directors, or our or their affiliates, for services rendered to us prior to or in connection with the completion of our initial business combination, other than the following payments, none of which will be made from the proceeds of this offering held in the trust account prior to the completion of our initial business combination: · Repayment of up to an aggregate of $300,000 in loans that we may draw down made to us by ou

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q 10-Q 2022-05-16 https://www.sec.gov/Archives/edgar/data/1870471/000141057822001734/daoo-20220331x10q.htm
10-K 10-K 2022-03-31 https://www.sec.gov/Archives/edgar/data/1870471/000141057822000787/daoo-20211231x10k.htm
SC 13G/A FORM SC 13G/A 2022-02-14 https://www.sec.gov/Archives/edgar/data/1870471/000106299322003995/formsc13ga.htm
10-Q 10-Q 2022-01-20 https://www.sec.gov/Archives/edgar/data/1870471/000141057822000042/daoo-20210930x10q.htm
8-K FORM 8-K 2022-01-11 https://www.sec.gov/Archives/edgar/data/1870471/000110465922003203/tm222525d1_8k.htm
SC 13G CRYPTO 1 ACQUISITION CORP. 2021-12-20 https://www.sec.gov/Archives/edgar/data/1870471/000090266421005320/p21-2714sc13g.htm
SC 13G FORM SC 13G 2021-12-17 https://www.sec.gov/Archives/edgar/data/1870471/000106299321013109/formsc13g.htm
SC 13G CRYPTO 1 ACQUISITION CORP 2021-12-17 https://www.sec.gov/Archives/edgar/data/1870471/000090266421005299/p21-2685sc13g.htm
8-K FORM 8-K 2021-12-10 https://www.sec.gov/Archives/edgar/data/1870471/000110465921148474/tm2135027d1_8k.htm
424B4 424B4 2021-12-08 https://www.sec.gov/Archives/edgar/data/1870471/000110465921147655/tm2132873-8_424b4.htm
3 OWNERSHIP DOCUMENT 2021-12-07 https://www.sec.gov/Archives/edgar/data/1870471/000110465921147131/xslF345X02/tm2134301d9_3.xml
3 OWNERSHIP DOCUMENT 2021-12-07 https://www.sec.gov/Archives/edgar/data/1870471/000110465921147130/xslF345X02/tm2134301d8_3.xml
3 OWNERSHIP DOCUMENT 2021-12-07 https://www.sec.gov/Archives/edgar/data/1870471/000110465921147129/xslF345X02/tm2134301d7_3.xml
3 OWNERSHIP DOCUMENT 2021-12-07 https://www.sec.gov/Archives/edgar/data/1870471/000110465921147128/xslF345X02/tm2134301d6_3.xml
3 OWNERSHIP DOCUMENT 2021-12-07 https://www.sec.gov/Archives/edgar/data/1870471/000110465921147125/xslF345X02/tm2134301d5_3.xml
3 OWNERSHIP DOCUMENT 2021-12-07 https://www.sec.gov/Archives/edgar/data/1870471/000110465921147123/xslF345X02/tm2134301d4_3.xml
3 OWNERSHIP DOCUMENT 2021-12-07 https://www.sec.gov/Archives/edgar/data/1870471/000110465921147120/xslF345X02/tm2134301d3_3.xml
3 OWNERSHIP DOCUMENT 2021-12-07 https://www.sec.gov/Archives/edgar/data/1870471/000110465921147119/xslF345X02/tm2134301d2_3.xml
3 OWNERSHIP DOCUMENT 2021-12-07 https://www.sec.gov/Archives/edgar/data/1870471/000110465921147116/xslF345X02/tm2134301d1_3.xml
EFFECT 2021-12-06 https://www.sec.gov/Archives/edgar/data/1870471/999999999521004576/xslEFFECTX01/primary_doc.xml
CERT 2021-12-03 https://www.sec.gov/Archives/edgar/data/1870471/000135445721001413/8A_Cert_DAOO.pdf
8-A12B 8-A12B 2021-12-03 https://www.sec.gov/Archives/edgar/data/1870471/000110465921146363/tm2134467d1_8a12b.htm
CORRESP 2021-12-03 https://www.sec.gov/Archives/edgar/data/1870471/000110465921146357/filename1.htm
CORRESP 2021-12-03 https://www.sec.gov/Archives/edgar/data/1870471/000110465921146355/filename1.htm
S-1/A S-1/A 2021-12-02 https://www.sec.gov/Archives/edgar/data/1870471/000110465921145613/tm2132873-4_s1a.htm
CORRESP 2021-12-01 https://www.sec.gov/Archives/edgar/data/1870471/000110465921145614/filename1.htm
UPLOAD 2021-12-01 https://www.sec.gov/Archives/edgar/data/1870471/000000000021014486/filename1.pdf
S-1/A S-1/A 2021-11-30 https://www.sec.gov/Archives/edgar/data/1870471/000110465921144626/tm2132873-1_s1.htm
CORRESP 2021-11-29 https://www.sec.gov/Archives/edgar/data/1870471/000110465921144633/filename1.htm
UPLOAD 2021-11-29 https://www.sec.gov/Archives/edgar/data/1870471/000000000021014332/filename1.pdf
S-1/A FORM S-1/A 2021-11-15 https://www.sec.gov/Archives/edgar/data/1870471/000110465921139113/tm2132873d2_s1a.htm
S-1 FORM S-1 2021-11-12 https://www.sec.gov/Archives/edgar/data/1870471/000110465921138253/tm2124028d3_s1.htm
CORRESP 2021-11-12 https://www.sec.gov/Archives/edgar/data/1870471/000110465921138257/filename1.htm
DRS/A 2021-10-20 https://www.sec.gov/Archives/edgar/data/1870471/000110465921128138/filename1.htm
UPLOAD 2021-09-17 https://www.sec.gov/Archives/edgar/data/1870471/000000000021011283/filename1.pdf
DRS 2021-08-25 https://www.sec.gov/Archives/edgar/data/1870471/000110465921109085/filename1.htm